WallStSmart

Kimberly-Clark Corporation (KMB)vsMagnera Corp placeholder (MAGN)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Kimberly-Clark Corporation generates 407% more annual revenue ($16.56B vs $3.27B). KMB leads profitability with a 12.8% profit margin vs -3.4%. KMB appears more attractively valued with a PEG of 2.07. KMB earns a higher WallStSmart Score of 58/100 (C).

KMB

Buy

58

out of 100

Grade: C

Growth: 4.7Profit: 8.0Value: 4.0Quality: 4.0
Piotroski: 3/9Altman Z: 2.19

MAGN

Hold

41

out of 100

Grade: D

Growth: 5.3Profit: 3.0Value: 4.0Quality: 5.5
Piotroski: 4/9Altman Z: 1.20
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

KMBSignificantly Overvalued (-36.3%)

Margin of Safety

-36.3%

Fair Value

$78.97

Current Price

$99.04

$20.07 premium

UndervaluedFair: $78.97Overvalued

Intrinsic value data unavailable for MAGN.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

KMB1 strengths · Avg: 10.0/10
Return on EquityProfitability
118.0%10/10

Every $100 of equity generates 118 in profit

MAGN1 strengths · Avg: 10.0/10
Price/BookValuation
0.4x10/10

Reasonable price relative to book value

Areas to Watch

KMB4 concerns · Avg: 3.8/10
PEG RatioValuation
2.074/10

Expensive relative to growth rate

Price/BookValuation
18.3x4/10

Trading at 18.3x book value

Revenue GrowthGrowth
2.7%4/10

2.7% revenue growth

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

MAGN4 concerns · Avg: 3.3/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$399.43M3/10

Smaller company, higher risk/reward

Operating MarginProfitability
4.2%3/10

Operating margin of 4.2%

Debt/EquityHealth
1.893/10

Elevated debt levels

Comparative Analysis Report

WallStSmart Research

Bull Case : KMB

The strongest argument for KMB centers on Return on Equity.

Bull Case : MAGN

The strongest argument for MAGN centers on Price/Book.

Bear Case : KMB

The primary concerns for KMB are PEG Ratio, Price/Book, Revenue Growth. Debt-to-equity of 3.94 is elevated, increasing financial risk.

Bear Case : MAGN

The primary concerns for MAGN are EPS Growth, Market Cap, Operating Margin. Debt-to-equity of 1.89 is elevated, increasing financial risk.

Key Dynamics to Monitor

KMB profiles as a value stock while MAGN is a turnaround play — different risk/reward profiles.

KMB is growing revenue faster at 2.7% — sustainability is the question.

KMB generates stronger free cash flow (321M), providing more financial flexibility.

Monitor HOUSEHOLD & PERSONAL PRODUCTS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

KMB scores higher overall (58/100 vs 41/100). Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Kimberly-Clark Corporation

CONSUMER DEFENSIVE · HOUSEHOLD & PERSONAL PRODUCTS · USA

Kimberly-Clark Corporation is an American multinational personal care corporation that produces mostly paper-based consumer products. The company manufactures sanitary paper products and surgical & medical instruments. Kimberly-Clark brand name products include Kleenex facial tissue, Kotex feminine hygiene products, Cottonelle, Scott and Andrex toilet paper, Wypall utility wipes, KimWipes scientific cleaning wipes and Huggies disposable diapers and baby wipes.

Visit Website →

Magnera Corp placeholder

CONSUMER DEFENSIVE · HOUSEHOLD & PERSONAL PRODUCTS · USA

Magnera Corp (MAGN) is a leading technology firm dedicated to pioneering advanced data analytics and machine learning solutions, playing a vital role in the digital transformation of various sectors. The company's strategic emphasis on operational efficiency is backed by a diverse portfolio of proprietary technologies, reflecting its strong commitment to research and development. Magnera Corp's innovative approach and adaptability not only position it favorably within the technology landscape, but also present an attractive investment opportunity for institutional investors aiming to capitalize on transformative growth trends.

Want to dig deeper into these stocks?